The Lawyer Asia Pacific 150 is the only research report to provide a ranking of the top 100 independent local firms and top 50 global firms in the region. The report offers critical review of some of the fastest growing firms and their strategies, a country-by-country guide to leading legal advisers and legal services market trends, plus exclusive insight into the current business development opportunities in the Asia Pacific. Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
Herbert Smith has set up a pharmaceutical and healthcare group which pulls together the existing expertise of seven partners.
But the partners will not concentrate entirely on this area of law, said associated partner, Bill Moodie.
Clients include Boeghringer Manheim, Hoffman Laroche and some work for Zeneca. The group will be touting for work among smaller pharmaceutical firms and service companies. Blue chip drugs manufacturers are increasingly outsourcing work to these companies.
Christopher Tootal, an intellectual property and patent expert, has been involved in the industry for the past 30 years.
IP partners Andrew Rich and Mark Shillito are also in the group. Regulatory experience will be provided by Elizabeth McKnight, while advice on flotations and venture capital will come from David Willis and Tim Steadman.
The move follows the establishment three months ago of a specialist service for the drugs industry at Morgan Bruce.